Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Investing

Merck : MRK

All Merck Articles

1086 Articles

Paul Ausick | Oct 22, 2015 at 4:01 PM EDT

The 4 Stocks That Dominated the DJIA on Thursday

ThinkstockOctober 22, 2015: Markets opened higher on Thursday on a better-than-expected report on new claims for unemployment benefits, but the…

Paul Ausick | Oct 20, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the Dow Tuesday

ThinkstockOctober 20, 2015: Markets opened lower on again on Tuesday as investors trailed along after mixed Asian and European equities…

Paul Ausick | Oct 16, 2015 at 4:01 PM EDT

The 4 Stocks That Lifted the DJIA on Friday

ThinkstockOctober 16, 2015: Markets opened higher on Friday following an expected drop of 0.2% in U.S. industrial production and a…

Paul Ausick | Oct 13, 2015 at 4:01 PM EDT

The 4 Stocks That Sank the Dow on Tuesday

thinkstockOctober 13, 2015: Markets opened lower on Tuesday following disappointing economic data from China and a lack of any U.S.…

Chris Lange | Oct 12, 2015 at 9:25 AM EDT

Short Sellers Become More Selective on Major Pharma

The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Oct 7, 2015 at 4:01 PM EDT

The 4 Stocks That Boosted the Dow on Wednesday

thinkstockOctober 7, 2015: Markets opened higher on Wednesday tagging along on a rise in European equities. The upbeat start gave…

Chris Lange | Oct 3, 2015 at 9:15 AM EDT

5 Big FDA Decisions Expected in October

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of October and…

Lee Jackson | Oct 2, 2015 at 10:25 AM EDT

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

Wikimedia CommonsIf there was ever a time when investors are thrilled to see the calendar change it could be now.…

Chris Lange | Sep 25, 2015 at 8:40 AM EDT

Short Sellers Boost Positions in Major Pharma

The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Sep 24, 2015 at 9:45 AM EDT

Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter

One positive from the hammering the pharmaceutical stocks have taken is the Merrill Lynch analysts say investors have been given…

Paul Ausick | Sep 18, 2015 at 4:01 PM EDT

The 4 Stocks That Tanked the Dow on Friday

thinkstockSeptember 18, 2015: Markets opened lower on Friday as investors reacted to further uncertainty related to an interest rate hike.…

Paul Ausick | Sep 15, 2015 at 4:01 PM EDT

The 4 Stocks That Boosted the Dow on Tuesday

thinkstockSeptember 15, 2015: Markets opened higher on Tuesday following early morning reports of an increase in retail sales and drops…

Chris Lange | Sep 11, 2015 at 8:25 AM EDT

Short Sellers Become More Selective in Major Pharma

The short interest data have been released for the August 31 settlement date, and for the selected pharmaceutical stocks, short…

Paul Ausick | Sep 10, 2015 at 4:01 PM EDT

The 4 Stocks That Lifted the Dow on Thursday

thinkstockSeptember 10, 2015: Markets opened lower on Thursday after a rather lackluster performance in Asia’s equity markets and more of…

Trey Thoelcke | Sep 2, 2015 at 10:05 AM EDT

The Best and Worst Dow Performers During the Recent Collapse

As in all outbreaks of volatility, there are islands of relative stability drowned out by the companies causing the loudest…

1 … 40 41 42 43 44 … 73

Merck : MRK

All Merck Articles

The 4 Stocks That Dominated the DJIA on Thursday

The 4 Stocks That Weighed on the Dow Tuesday

The 4 Stocks That Lifted the DJIA on Friday

The 4 Stocks That Sank the Dow on Tuesday

Short Sellers Become More Selective on Major Pharma

The 4 Stocks That Boosted the Dow on Wednesday

5 Big FDA Decisions Expected in October

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

Short Sellers Boost Positions in Major Pharma

Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter

The 4 Stocks That Tanked the Dow on Friday

The 4 Stocks That Boosted the Dow on Tuesday

Short Sellers Become More Selective in Major Pharma

The 4 Stocks That Lifted the Dow on Thursday

The Best and Worst Dow Performers During the Recent Collapse

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

YMAX’s 1.33% Fee Is Just the Start: How a Fund-of-Funds Structure Is Quietly Stacking Costs on Top of Costs

How a Couple With $1 Million in Retirement Can Build a Tax-Efficient $2,392 Monthly Income Stream Using 2 Vanguard ETFs

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here’s Who Wins

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here's Who Wins

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

YMAX’s 1.33% Fee Is Just the Start: How a Fund-of-Funds Structure Is Quietly Stacking Costs on Top of Costs

How a Couple With $1 Million in Retirement Can Build a Tax-Efficient $2,392 Monthly Income Stream Using 2 Vanguard ETFs

Merck : MRK

All Merck Articles

The 4 Stocks That Dominated the DJIA on Thursday

The 4 Stocks That Weighed on the Dow Tuesday

The 4 Stocks That Lifted the DJIA on Friday

The 4 Stocks That Sank the Dow on Tuesday

Short Sellers Become More Selective on Major Pharma

The 4 Stocks That Boosted the Dow on Wednesday

5 Big FDA Decisions Expected in October

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

Short Sellers Boost Positions in Major Pharma

Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter

The 4 Stocks That Tanked the Dow on Friday

The 4 Stocks That Boosted the Dow on Tuesday

Short Sellers Become More Selective in Major Pharma

The 4 Stocks That Lifted the Dow on Thursday

The Best and Worst Dow Performers During the Recent Collapse

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

YMAX’s 1.33% Fee Is Just the Start: How a Fund-of-Funds Structure Is Quietly Stacking Costs on Top of Costs

How a Couple With $1 Million in Retirement Can Build a Tax-Efficient $2,392 Monthly Income Stream Using 2 Vanguard ETFs

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here’s Who Wins

Featured Reads

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here's Who Wins

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back